Forum Financial Management LP Increases Position in HCA Healthcare, Inc. $HCA

Forum Financial Management LP increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,098 shares of the company’s stock after acquiring an additional 65 shares during the period. Forum Financial Management LP’s holdings in HCA Healthcare were worth $421,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Ethic Inc. boosted its position in HCA Healthcare by 1.7% during the second quarter. Ethic Inc. now owns 9,563 shares of the company’s stock valued at $3,627,000 after buying an additional 159 shares during the period. Caliber Wealth Management LLC KS boosted its position in HCA Healthcare by 6.3% during the second quarter. Caliber Wealth Management LLC KS now owns 8,180 shares of the company’s stock valued at $3,134,000 after buying an additional 482 shares during the period. Cookson Peirce & Co. Inc. purchased a new stake in HCA Healthcare during the second quarter valued at about $239,000. Greenup Street Wealth Management LLC boosted its position in HCA Healthcare by 1.5% during the second quarter. Greenup Street Wealth Management LLC now owns 6,231 shares of the company’s stock valued at $2,387,000 after buying an additional 90 shares during the period. Finally, Maj Invest Holding A S boosted its position in HCA Healthcare by 0.4% during the second quarter. Maj Invest Holding A S now owns 319,050 shares of the company’s stock valued at $122,228,000 after buying an additional 1,224 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $446.58 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $461.56. The company has a 50 day simple moving average of $414.84 and a two-hundred day simple moving average of $382.03. The company has a market capitalization of $104.50 billion, a price-to-earnings ratio of 17.26, a P/E/G ratio of 1.41 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the firm earned $4.90 earnings per share. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday. Barclays increased their target price on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. The Goldman Sachs Group initiated coverage on shares of HCA Healthcare in a report on Tuesday, October 14th. They set a “buy” rating and a $470.00 target price for the company. Truist Financial set a $460.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 14th. Finally, Morgan Stanley decreased their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $437.19.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.